top of page

ACG Strategic Insights

Strategic Intelligence That Drives Results

What a Competitor's Patent Filing Tells You About Their Strategy

  • Writer: Jerry Justice
    Jerry Justice
  • Jul 14
  • 7 min read
A close-up of an executive reviewing a complex technical blueprint with a magnifying glass on a sleek boardroom table.
The Details Competitors Missed Are Sitting In Plain Sight

Most executives read a competitor's patent filing the way they read a parking ticket. Annoying, someone else's problem, best left with legal.


That habit carries a real cost. Executive teams track competitor earnings, product launches, and leadership changes closely, but patent filings rarely get the same attention outside the legal department. If you're waiting for the press release to learn what a rival is building, you're already late.


A patent filing is the one document a company cannot spin. Earnings calls get scripted weeks in advance, and press releases pass through rounds of review before anyone outside the building sees them. A patent application has to disclose the actual technical problem a company is solving and the approach it chose. Nobody files a patent to shape perception. They file it to protect something they intend to use, which makes patent activity one of the more honest signals available to a strategist, and one of the most underused.


A Patent Filing Is A Confession


Kevin G. Rivette, Henry R. Nothhaft, and David Kline made this case in Harvard Business Review in 2000, in a piece titled Discovering New Value in Intellectual Property. Their opening example was Richard Thoman, who had just taken over as CEO of the twenty billion dollar Xerox Corporation. Most chief executives asked how they intended to grow shareholder value would point to new products or an acquisition pipeline. Thoman pointed to something that never showed up on the balance sheet at all, the company's patent portfolio, and the strategic intelligence buried inside it.


More than two decades later the logic holds up even better. Every serious technology company now files patents the way manufacturers once filed inventory reports, as a running record of what they are building rather than what they are announcing.


Where a company files matters as much as what it files. A filing only in the home market likely protects a domestic position. Parallel filings across the United States, the European Union, and China signal a go to market timeline closer than any public statement has suggested, often a more reliable predictor of expansion plans than a company's investor materials.


What A Filing Reveals Before The Product Ships


Amazon's drone delivery program is the clearest public case of the gap between filing and launch. The company spent years filing patents covering aerial delivery infrastructure, from beehive shaped warehouse towers to sense and avoid systems, before the concept was even announced publicly in December 2013. Genuinely commercial delivery did not arrive until 2022, when the company opened limited sign ups in Lockeford, California. Amazon ran the same playbook with cashierless retail, filing the core patents behind its "Just Walk Out" system years before the first Amazon Go store opened in 2018.


The pattern holds outside consumer technology too. According to DrugPatentWatch, a pharmaceutical patent application typically publishes about eighteen months after filing, well before any clinical trial registry confirms a competitor's therapeutic focus. A company tracking a rival's filings from the start of a discovery program can gain six months or more of advance notice on where that pipeline is headed. That is real lead time to redirect a program, pursue a license, or simply avoid being blindsided by a competitor's next announcement.


What A Pattern Of Filings Actually Tells You


One caveat belongs here before you overreact to a single document. Estimates reported by Forbes put the share of patents never licensed or commercialized at roughly ninety five percent. Most filings are noise, defensive housekeeping, or ideas that quietly die in a drawer. A single filing tells you very little on its own.


A pattern tells you something different. When several filings cluster around one technical problem, ask:


  • Which technologies keep reappearing, and does the inventor list suggest a team was hired specifically to solve this problem?

  • Does the filing strengthen an existing product line, or read like the seed of an entirely separate business?


Apple's wearable history is a clean illustration. Apple filed for a "wrist-worn electronic device" in January 2011, then followed it with a 2013 filing for a biometric identification system based on plethysmography, the light sensor technology that later became the Watch's heart rate hardware. Both filings predate Tim Cook's September 2014 announcement by one to three years. Neither filing alone would have told you much. Together, they described a specific product years before the world saw it.


Reading The Filing As A Boundary, Not Just A Data Point


Here is where most executives stop short. They treat a competitor's patent as market research, a curiosity to note and move past. The more useful read is different. A patent claim covering a process, component, or method your own product depends on is not just information. It is a line a competitor has drawn around territory they intend to defend.


Nothing changes the day the filing publishes. Operations continue normally, customers notice nothing, revenue stays stable. Then the patent issues. Licensing talks start. The boundary that looked invisible eighteen months earlier has suddenly become very real, and the greatest risk usually isn't a lawsuit. It's finding out that someone else now controls the future direction of a technology central to your business model.


I've watched leadership teams run into a blocking patent only after their own engineering team hit a wall trying to build around it, months into a product cycle that should have been redirected the moment the filing became public. The information was sitting in the public record the entire time. Nobody on the strategy side was reading it.


Your Filings Are Being Read Too


Every patent your own organization submits tells part of your story right back. It can reveal where research funding is increasing, which adjacent markets you're evaluating, or which manufacturing capability isn't public yet. Each filing has to satisfy two goals at once: protect the invention, and reveal no more strategic direction than necessary. Careful drafting keeps those goals from conflicting.


Sun Tzu wrote in The Art of War that "all warfare is based on deception." Business is not warfare, but the same discipline applies. Strategic advantage tends to favor the organization that reads what others reveal while carefully managing what it discloses.


Strategic Responses To A Competitor's Patent Filing


Finding that a rival has filed on something your business depends on calls for deliberate action, not panic. An application is not yet a granted right, it's an open negotiation with a patent examiner, and you have real options.


  • File third party observations. Many jurisdictions let you submit prior art anonymously, and if the technology was public before the competitor's filing date, you can narrow or defeat the claim.

  • Direct engineering toward a genuine design around, provided you start early enough that it doesn't feel like triage.

  • Pursue cross licensing if your own portfolio gives you something to trade, turning a legal threat into a business arrangement.

  • Treat a dense cluster of filings around one target as an acquisition signal, pointing you toward a smaller company worth buying before a larger rival does.


None of this works if the filing sits in a legal queue for six months before anyone with a strategic mandate sees it. The underlying logic of the patent system supports moving fast here. The disclosure a company makes in exchange for exclusivity is, as the US Supreme Court put it in J.E.M. Ag Supply v. Pioneer Hi-Bred, "the quid pro quo of the right to exclude." That bargain is the entire reason this information is sitting in public view for you to use.


Building Patent Intelligence Into How You Operate


Shifting an organization to treat patent activity as a strategic asset, not a legal footnote, takes structural change. A few practices separate the companies that extract real value from the ones that just generate reports:


  • Legal briefs leadership on significant competitor filings in business language, not legal terminology.

  • Product leaders compare filing activity against their own roadmap on a recurring basis.

  • Boards review intellectual property developments alongside market, financial, and operational risk.


Kevin Rivette, whose book on this topic helped define the field two decades ago, put it plainly in a 2019 interview marking its anniversary: "Rembrandts was more about business strategies than just monetisation." That is the mindset shift. The question stops being "can we challenge this patent" and becomes "what future is our competitor preparing to enter."


Strategy Leaves Clues


The companies that shape industries rarely announce every move before making it. They leave clues, and patent filings are among the clearest. Reading those clues early buys something more valuable than legal awareness: time to strengthen your pipeline, diversify risk, and reposition investment before the pressure shows up in a quarterly earnings call.


Your competitors are already telling you where they're headed. The only real question is whether anyone in your organization is reading the filing.


Where Growth Outpaces The Org Chart


Most of the pressure points senior leadership teams bring to us don't sit neatly inside one function. A patent filing that threatens a core product dependency is simultaneously a legal question, an R&D roadmap question, and a competitive strategy question, and it tends to surface exactly when a company is scaling fastest. Mid-market and Fortune 1000 executives who wait for these intersection points to resolve themselves usually end up managing a crisis instead of a decision. If a competitor's IP position has your team second guessing your own roadmap, a confidential conversation is the fastest way to find out what your real options are. Reach out through Aspirations Consulting Group at https://www.aspirations-group.com.


Stay Ahead Of The Filing


ACG Strategic Insights is written for executives who want to see around corners before the rest of the market does. Request a complimentary subscription at https://www.aspirations-group.com/subscription and get tomorrow's thinking on strategy, leadership, and finance delivered straight to your inbox, five days a week.


Thanks for reading!


~ Jerry Justice

Living to Serve, Serving to Lead™

Comments


ACG Diagnostic Series™

Know exactly where you stand.

 

Two suites. Four instruments. Rigorous assessments of your leadership and financial judgment — built for serious leaders.

 

Leadership Suite
 

ACG Leadership Diagnostic™ 
ACG Leadership Assessment™ 

Financial Edge Suite
 

ACG Financial Edge Diagnostic™ 
ACG Financial Edge Assessment™

©2026 ASPIRATIONS CONSULTING GROUP, LLC™.  ALL RIGHTS RESERVED.

bottom of page